4.6 Review

SARS-CoV-2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

DisProt in 2022: improved quality and accessibility of protein intrinsic disorder annotation

Federica Quaglia et al.

Summary: The latest update of DisProt version 9 includes a restyled web interface, refactored IDPO, improvements in curation process, and around 30% content growth. The newly implemented reviewing process and curator training aim to provide higher quality and more consistent annotations. Integration with APICURON and adoption of MIADE standard, along with collaborations with GO and ECO consortia and support from ELIXIR infrastructure, enhance interoperability.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

UniProt: the universal protein knowledgebase in 2021

Alex Bateman et al.

Summary: The UniProt Knowledgebase aims to provide users with a comprehensive, high-quality set of protein sequences annotated with functional information. Updates over the past two years have increased the number of sequences to approximately 190 million, with new methods to assess proteome completeness and quality. UniProtKB has responded to the COVID-19 pandemic by expertly curating relevant entries and making them rapidly available through a dedicated portal.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant

Changshuo Wei et al.

Summary: The study suggests that the rapid accumulation of mutations in the SARS-CoV-2 Omicron variant may have originated from humans jumping to mice and then back to humans, indicating an inter-species evolutionary trajectory.

JOURNAL OF GENETICS AND GENOMICS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.
Editorial Material Medicine, General & Internal

SARS-CoV-2 variants and ending the COVID-19 pandemic

Arnaud Fontanet et al.

LANCET (2021)

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Article Multidisciplinary Sciences

Where did ‘weird’ Omicron come from?

Kai Kupferschmidt

SCIENCE (2021)

Article Multidisciplinary Sciences

Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes

Mayank Batra et al.

Summary: This study found that titers of IgG targeting N-protein of SARS-CoV2 at admission are related to the clinical course of the disease. Higher CCI and IL6 levels were independently associated with in-hospital mortality while maintaining a high S/Co ratio (>1.5) also led to MICU admission and longer hospital stays.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

Cong Zeng et al.

Summary: This study investigates the neutralization sensitivity of SARS-CoV-2 variants containing the Q677H mutation and highlights the increased viral infectivity and neutralizing antibody resistance conferred by the mutation. The research emphasizes the importance of epistatic interactions between SARS-CoV-2 spike mutations and the continued need to monitor VOCs carrying the Q677H mutation.
Article Multidisciplinary Sciences

Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes

Ziliang Zhou et al.

Summary: SARS-CoV-2 ORF7a interacts efficiently with human CD14(+) monocytes, triggering inflammatory responses such as decreased HLA expression and increased production of proinflammatory cytokines. This suggests that ORF7a may be a key immunomodulating factor in the severe immune response seen in COVID-19 patients.

ISCIENCE (2021)

Article Cell Biology

Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD

John M. Errico et al.

Summary: This study utilized cryo-EM to characterize two protective anti-SARS-CoV-2 murine monoclonal antibodies, revealing similarities between epitopes targeted by human and murine B cells. The findings suggest that SARS-CoV-2 might evade therapeutic antibodies with a limited set of mutations, underscoring the importance of combination mAb therapeutics. It also showed distinct inhibitory mechanisms used by RBD-specific mAbs in neutralizing SARS-CoV-2 infection.

CELL REPORTS (2021)

Article Biophysics

1H, 13C and 15N Backbone chemical shift assignments of the n-terminal and central intrinsically disordered domains of SARS-CoV-2 nucleoprotein

Serafima Guseva et al.

Summary: The nucleoprotein (N) from SARS-CoV-2 plays an important role in the viral replication transcription complex and in protecting the viral genome from the host immune system. N is a 419 amino acid multidomain protein with two folded domains and a predicted intrinsically disordered region, for which atomic resolution information is currently lacking.

BIOMOLECULAR NMR ASSIGNMENTS (2021)

Editorial Material Microbiology

An NTD supersite of attack

Shee-Mei Lok

Summary: Recent studies have identified highly protective antibodies specific to the N-terminal domain (NTD) of the SARS-CoV-2 spike protein, targeting a conserved supersite.

CELL HOST & MICROBE (2021)

Review Virology

Neutralizing Antibody Therapeutics for COVID-19

Aeron C. Hurt et al.

Summary: The emergence of SARS-CoV-2 and the subsequent COVID-19 pandemic have created an urgent need for effective therapeutic strategies. Neutralizing antibodies have shown potential in treating and preventing COVID-19, but their efficacy in severe cases remains varied. Treatment may lead to the formation of antiviral resistant escape mutants, highlighting the importance of exploring strategies to minimize risk.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA

Jasmine Cubuk et al.

Summary: The study reveals that SARS-CoV-2 nucleocapsid (N) protein undergoes liquid-liquid phase separation with RNA, and provides molecular details of N protein through single-molecule spectroscopy with all-atom simulations, showing its multivalent RNA-binding nature and interactions that may drive RNA compaction.

NATURE COMMUNICATIONS (2021)

Article Microbiology

Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity

Sang Ho Park et al.

Summary: The E protein of SARS-CoV-2 is a crucial structural protein involved in the viral replication cycle. Studies have shown interactions between E protein and ion channel inhibitors, with the N-terminal region identified as the primary binding site. Mutational and chemical shift analyses highlight the significant role of Asn15 in maintaining the protein conformation near the binding site.

PLOS PATHOGENS (2021)

Review Biochemistry & Molecular Biology

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention

Juan Pablo Jaworski

Summary: The SARS-CoV-2 pandemic has caused unprecedented global health and economic crises. Various vaccine approaches and repurposed drugs are being evaluated, while nMAbs targeting the virus spike glycoprotein show promise. Large-scale production and high costs are key limitations for their clinical use. Collaboration, rapid development, safety evaluation, and production planning are crucial for controlling the COVID-19 pandemic.

BIOMEDICAL JOURNAL (2021)

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Article Biochemistry & Molecular Biology

Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs

David M. Kern et al.

Summary: The cryo-EM structure of SARS-CoV-2 ORF3a reveals a new fold conserved in coronaviruses, with functional experiments showing ion channel activity that could be crucial for viral infectivity. Deletion of 3a in SARS-CoV-1 reduces viral titer and morbidity in mice, indicating it could be a potential target for vaccines or therapeutics. The study also identifies structural features of 3a and potential inhibitors that could be used in treating COVID-19 and other coronavirus diseases.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 Variants in Patients with Immunosuppression

Lawrence Corey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain

Chao Wu et al.

Summary: The study characterizes the biochemical properties of the nucleocapsid protein N encoded by SARS-CoV-2 and highlights the value of using N domains as highly specific and sensitive diagnostic markers. The research provides insights into N oligomerization, RNA binding, phosphorylation regulation, and immunogenicity of different N domains.

ISCIENCE (2021)

Review Immunology

Viral targets for vaccines against COVID-19

Lianpan Dai et al.

Summary: The urgent need for vaccines to control the COVID-19 pandemic has led to the rapid development of multiple vaccine candidates, with some showing positive results in late-stage clinical trials. This article discusses the viral elements used in these candidates, the reasons why they are good targets for the immune system, and their implications for protective immunity. Dai and Gao highlight the importance of selecting the right viral targets in vaccine development to ensure an effective immune response and the overall safety and efficacy of the vaccine.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Virology

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies

Craig Fenwick et al.

Summary: In this study, antibody responses to SARS-CoV-2 were evaluated in acute and postinfection subjects. The results show that responses against viral S and N proteins were equally sensitive in acute phase, but N responses decreased in postinfection phase while S responses persisted. The most sensitive assay used the native S protein trimer, suggesting its importance in estimating SARS-CoV-2 infections and assessing vaccine-induced responses.

JOURNAL OF VIROLOGY (2021)

Article Biochemistry & Molecular Biology

DisProt: intrinsic protein disorder annotation in 2020

Andras Hatos et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase

Quan Wang et al.

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Article Multidisciplinary Sciences

Site-specific glycan analysis of the SARS-CoV-2 spike

Yasunori Watanabe et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Yan Gao et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

Article Microbiology

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Andrew Rambaut et al.

NATURE MICROBIOLOGY (2020)

Article Multidisciplinary Sciences

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

Donghyuk Shin et al.

NATURE (2020)

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects

Antoni G. Wrobel et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

Evolution and epidemic spread of SARS-CoV-2 in Brazil

Darlan S. Candido et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Identification of novel molecular determinants of co-receptor usage in HIV-1 subtype F V3 envelope sequences

Maximiliano Distefano et al.

SCIENTIFIC REPORTS (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Katharina Schubert et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation

Mary Hongying Cheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition

Oliver C. Grant et al.

SCIENTIFIC REPORTS (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs

Theodora Myrto Perdikari et al.

EMBO JOURNAL (2020)

Article Multidisciplinary Sciences

Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates

Adriana Savastano et al.

NATURE COMMUNICATIONS (2020)

Letter Biochemistry & Molecular Biology

Crystal structure of SARS-CoV-2 nsp10/nsp16 2′-O-methylase and its implication on antiviral drug design

Sheng Lin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Biotechnology & Applied Microbiology

Dengue viruses and promising envelope protein domain III-based vaccines

Hossein Fahimi et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)

Editorial Material Biochemistry & Molecular Biology

How Do Intrinsically Disordered Viral Proteins Hijack the Cell?

H. Jane Dyson et al.

BIOCHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Correlating Flavivirus virulence and levels of intrinsic disorder in shell proteins: protective roles vs. immune evasion

Gerard Kian-Meng Goh et al.

MOLECULAR BIOSYSTEMS (2016)

Review Biotechnology & Applied Microbiology

Coronaviruses - drug discovery and therapeutic options

Alimuddin Zumla et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Article Biochemistry & Molecular Biology

Antibody Recognition of Disordered Antigens

Christopher A. MacRaild et al.

STRUCTURE (2016)

Article Chemistry, Multidisciplinary

Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering

Giancarlo Tria et al.

Review Chemistry, Multidisciplinary

Classification of Intrinsically Disordered Regions and Proteins

Robin van der Lee et al.

CHEMICAL REVIEWS (2014)

Review Immunology

The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development

Robert J. O'Connell et al.

EXPERT REVIEW OF VACCINES (2014)

Article Biochemistry & Molecular Biology

Orderly order in protein intrinsic disorder distribution: disorder in 3500 proteomes from viruses and the three domains of life

Bin Xue et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2012)

Article Biochemistry & Molecular Biology

ViralZone: a knowledge resource to understand virus diversity

Chantal Hulo et al.

NUCLEIC ACIDS RESEARCH (2011)

Review Biochemistry & Molecular Biology

Virus glycosylation: role in virulence and immune interactions

David J. Vigerust et al.

TRENDS IN MICROBIOLOGY (2007)

Article Biochemistry & Molecular Biology

Proportion of solvent-exposed amino acids in a protein and rate of protein evolution

Yeong-Shin Lin et al.

MOLECULAR BIOLOGY AND EVOLUTION (2007)

Review Biochemistry & Molecular Biology

Assessing protein disorder and induced folding

V Receveur-Brechot et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Evolutionary rate heterogeneity in proteins with long disordered regions

CJ Brown et al.

JOURNAL OF MOLECULAR EVOLUTION (2002)